MAX TRIGGER
MAX TRIGGER, licence 80052935: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- M.D Science Lab LLC
- NPN or DIN-HM
- 80052935
- Status
- Active licence
- Licence date
- 7 August 2014
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Turnera diffusa Willd. ex Schult.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Oxyde de zinc | 7.5 mg | Not calculated |
| L-arginine Source : Chlorhydrate de L-arginine | 75.0 mg | Not calculated |
| Epimedium grandiflorum Source : leaf standardized extract | 50.0 mg | Not calculated |
| Sélénium Source : Sélénométhionine | 25.0 mcg | Not calculated |
| Tribulus terrestris Source : Fruit | 250.0 mg | Not calculated |
| Tribulus terrestris Source : Fruit Potency : 40.0 % saponins | Not specified | Not calculated |
| Cnidium monnierie Source : Graine(s) | 15.0 mg | Not calculated |
| Turnera diffusa var. aphrodisiaca Source : Feuilles | 25.0 mg | Not calculated |
| Ginkgo biloba Source : leaf standardized extract | 50.0 mg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 10.0 mg | Not calculated |
| Avena sativa Source : Plante entière (extrait) Extraction ratio : 10:1 Dry plant equivalent : 2500 mg | 250.0 mg | Not calculated |
| Serenoa repens Source : Fruit (standardized extract) | 160.0 mg | Not calculated |
| Eurycoma Longifolia Source : Extrait de racine Extraction ratio : 100:1 Dry plant equivalent : 5000 mg | 50.0 mg | Not calculated |
Non-medicinal ingredients
Acide stéarique, Cellulose microcristalline, Phosphate de calcium, dibasique, Croscarmellose sodium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 2.0 Comprimé | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins Helps in the development and maintenance of bones and teeth. Helps in tissue formation. Helps to maintain proper muscle function. Helps to maintain healthy skin. Helps to maintain immune function. Helps in connective tissue formation. An antioxidant for the maintenance of good health. Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate bening prostatic hyperplasia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80052935
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.